Financially Strong Year-End: AbbVie Exceeds Expectations

AbbVie is a global biopharmaceutical company specializing in the research and development of drugs in areas such as immunology, oncology, neurosciences, and aesthetic medicine. The company is particularly known for its blockbuster Humira, which inhibits inflammation and is one of the best-selling drugs worldwide. In recent years, AbbVie has increasingly focused on pipeline expansions to offset declining revenues due to the patent expiration of Humira. With acquisitions like Allergan, the company is also strengthening its position in new business...